IRLNX
Price
$78.21
Change
+$0.27 (+0.35%)
Updated
Jul 16 closing price
Net Assets
1.55B
RGACX
Price
$80.30
Change
+$0.33 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

IRLNX vs RGACX

Header iconIRLNX vs RGACX Comparison
Open Charts IRLNX vs RGACXBanner chart's image
Voya Russell Large Cap Growth Idx Port I
Price$78.21
Change+$0.27 (+0.35%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R3
Price$80.30
Change+$0.33 (+0.41%)
VolumeN/A
Net Assets322.72B
IRLNX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRLNX vs. RGACX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRLNX is a StrongBuy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 323B vs. IRLNX (1.55B). IRLNX pays higher dividends than RGACX: IRLNX (0.17) vs RGACX (0.07). IRLNX was incepted earlier than RGACX: IRLNX (16 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than IRLNX (0.55). IRLNX is a more actively managed with annual turnover of: 29.00 vs. RGACX (25.00). IRLNX has a lower initial minimum investment than RGACX: IRLNX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 8.69 vs. IRLNX (0.96). IRLNX return over 5 years is better than : 69.27 vs. RGACX (43.38).
IRLNXRGACXIRLNX / RGACX
Total Expense Ratio0.430.9446%
Annual Report Gross Expense Ratio0.550.9459%
Fund Existence16 years23 years-
Gain YTD-4.89711.543-42%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B323B0%
Annual Yield % from dividends0.170.07231%
Returns for 1 year0.968.6911%
Returns for 3 years59.7057.35104%
Returns for 5 years69.2743.38160%
Returns for 10 years219.4977.95282%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT28.273.91
+16.05%
Summit Therapeutics
AC37.680.38
+1.02%
Associated Capital Group
ELMD18.420.18
+0.99%
Electromed
MTVA0.670.01
+0.93%
MetaVia Inc
CRI30.20-0.56
-1.82%
Carter's